Clearview Cancer Institute is a clinical research site located in Huntsville, Alabama, United States 35805.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Clearview Cancer Institute has participated in 53 clinical trials with 13 currently active.
Therapeutic areas: Non Hodgkin Lymphoma, Breast Cancer, Recurrent Uterine Corpus Carcinoma.
Sponsors: Rhizen Pharmaceuticals SA, NSABP Foundation Inc, GOG Foundation.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Clearview Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Clearview Cancer Institute has 53 clinical trials on record, with 13 currently active. Their work covers Non Hodgkin Lymphoma, Breast Cancer, Recurrent Uterine Corpus Carcinoma.
Clearview Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.